Skip to main content

Senate bill · S. 927 (119th Congress)

Protecting Pharmacies in Medicaid Act

U.S. Senate

Latest action Mar 11, 2025

Sponsor: Peter Welch (U.S. Senator for Vermont, Democratic)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Sep 9, 2026. About our data

Summary

Protecting Pharmacies in Medicaid Act This bill provides funds beginning in FY2026 for the Centers for Medicare & Medicaid Services to survey retail and non-retail pharmacies (e.g., mail-order pharmacies) to determine average prices of covered outpatient drugs under Medicaid. Pharmacies that fail to participate in the surveys are subject to civil penalties. The bill additionally provides funds for FY2026 for the Office of the Inspector General of the Department of Health and Human Services to study the results of the survey and report accordingly to Congress. The bill also requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

Senate Committee on Finance · U.S. Senate

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

Showing the cosponsors who are on Agora, A to Z. The official record may list more.

Read on Congress.gov (opens in a new tab)
  • Republican2

Shown in neutral colors by design; Agora is non-partisan.

As identified by Congress.gov.

Full history

  1. Mar 11, 2025

    Introduced

    Introduced in U.S. Senate

    U.S. Senate

  2. Mar 11, 2025

    Referred to committee

    Read twice and referred to the Committee on Finance.

  3. Mar 11, 2025

    Referred to committee

    Read twice and referred to the Committee on Finance.

Read the record